Background: The safety and efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors in hospitalized patients are unclear.
Purpose: To evaluate outcomes of inpatient SGLT2 inhibitor use.
Data Sources: MEDLINE, Embase, Emcare, and Cochrane databases were searched through 29 May 2024.